drugset / Trial / NCT07629401

Provide Pre-approval Expanded Access of LY3437943

NCT07629401

Expanded access Available Eli Lilly and Company

Summary

Provide pre-approval single patient expanded access of retatrutide for patients.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Retatrutide Protein / enzyme biologic

Indications

No indication recorded.